Accéder au contenu
Merck

Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice.

Science translational medicine (2020-08-18)
Shanna L Ashley, Michael W Sjoding, Antonia P Popova, Tracy X Cui, Matthew J Hoostal, Thomas M Schmidt, William R Branton, Michael G Dieterle, Nicole R Falkowski, Jennifer M Baker, Kevin J Hinkle, Kristine E Konopka, John R Erb-Downward, Gary B Huffnagle, Robert P Dickson
RÉSUMÉ

Inhaled oxygen, although commonly administered to patients with respiratory disease, causes severe lung injury in animals and is associated with poor clinical outcomes in humans. The relationship between hyperoxia, lung and gut microbiota, and lung injury is unknown. Here, we show that hyperoxia conferred a selective relative growth advantage on oxygen-tolerant respiratory microbial species (e.g., Staphylococcus aureus) as demonstrated by an observational study of critically ill patients receiving mechanical ventilation and experiments using neonatal and adult mouse models. During exposure of mice to hyperoxia, both lung and gut bacterial communities were altered, and these communities contributed to oxygen-induced lung injury. Disruption of lung and gut microbiota preceded lung injury, and variation in microbial communities correlated with variation in lung inflammation. Germ-free mice were protected from oxygen-induced lung injury, and systemic antibiotic treatment selectively modulated the severity of oxygen-induced lung injury in conventionally housed animals. These results suggest that inhaled oxygen may alter lung and gut microbial communities and that these communities could contribute to lung injury.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Sigma-Aldrich
Mouse IgM ELISA Kit